It can take more than 12 years and a major financial investment to bring a drug product to market.1 A drug product’s success relies on its efficacy, safety and manufacturing efficiencies along with the use of innovative strategies to meet evolving market needs and reinforcement of patient adherence. The importance of container closure and delivery systems as critical to success in the pharmaceutical industry is becoming more visible especially in respect to pharmaceutical and biotech organizations that desire to proactively minimize their risks.
Qualified container closure systems are necessary throughout a drug product’s lifecycle, spanning from pharmaceutical development through product discontinuation. Planning for the appropriate choice of container closure materials that can be viable during the different stages of the drug product lifecycle should consider several major factors that includes:
These elements should be evaluated appropriately and proportionally to each lifecycle stage, recognizing opportunities to identify areas for improvement.
Daikyo Crystal Zenith® technology is licensed from Daikyo Seiko, Ltd.